Tracking Stanley Druckenmiller's Duquesne Family Office Portfolio - Q3 2022 Update

Stanley Druckenmiller’s 13F portfolio value increased from $1.38B to $1.76B this quarter. Read more to know Druckenmiller’s Q3 2022 portfolio update.

Seeking Alpha

#Introduction Part 2:
My lab invented the open-source software CellProfiler and the imaging assay Cell Painting and we now focus on using our machine learning and deep learning skills for image-based profiling, to accelerate drug discovery and functional genomics. Our research led to the founding of Recursion, a clinical-stage techbio powered largely by the information in cell images.

#CellProfiler #DrugDiscovery #TechBio #RXRX #MachineLearning #DeepLearning